Curious about the top performers within the S&P500 index one hour before the close of the markets on Monday? Dive into the list of today's session's top gainers and losers for a comprehensive overview.
Seeking insights into today's market movers? Discover the S&P500 gap up and gap down stocks in today's session on Monday. Stay informed about the latest market trends.
While strong cash flow is a key indicator of stability, it doesn’t always translate to superior returns.
Some cash-heavy businesses struggle with inefficient spending, slowing demand, or weak competitive positioning.
Wall Street’s bearish price targets for the stocks in this article signal serious concerns.
Such forecasts are uncommon in an industry where maintaining cordial corporate relationships often trumps delivering the hard truth.
U.S. stocks advanced across the board by midday Friday, with the S&P 500 eyeing its ninth consecutive day of gains—poised for the longest winning streak since May 2024.
Cigna posts strong Q1 results with rising sales at Evernorth and Cigna Healthcare; raises 2025 EPS outlook to $29.60 amid higher medical cost ratio expectations.
AstraZeneca said on Friday that the full results from the two trials will be shared with regulatory authorities and presented at an upcoming medical meeting.
Health insurance company Cigna (NYSE:CI) reported Q1 CY2025 results topping the market’s revenue expectations, with sales up 14.4% year on year to $65.5 billion. Its non-GAAP profit of $6.74 per share was 6.2% above analysts’ consensus estimates.
The spotlight will likely be on the April non-farm payrolls report. Economists, on average, expect 133,000 job gains for the month, notably slower than the 228,00 pace for March.
